AAAAAA
Results: 1-25/47
Authors:
Zander, AR
Kroger, N
Citation: Ar. Zander et N. Kroger, High-dosage treatment of breast cancer - in favour, DEUT MED WO, 126(39), 2001, pp. 1091-1091
Authors:
Kruger, WH
Kroger, N
Togel, F
Renges, H
Badbaran, A
Hornung, R
Jung, R
Gutensohn, K
Gieseking, F
Janicke, F
Zander, AR
Citation: Wh. Kruger et al., Disseminated breast cancer cells prior to and after high-dose therapy, J HEMATH ST, 10(5), 2001, pp. 681-689
Authors:
Eiermann, TH
Freitag, S
Cortes-Dericks, L
Sahm, H
Zander, AR
Citation: Th. Eiermann et al., Jurkat cell-reactive anti-thymocyte globulin assessed ex vivo by flow cytometry persists three weeks in circulation, J HEMATH ST, 10(3), 2001, pp. 385-390
Authors:
Fehse, B
Chukhlovin, A
Kuhlcke, K
Marinetz, O
Vorwig, O
Renges, H
Kruger, W
Zabelina, T
Dudina, O
Finckenstein, FG
Kroger, N
Kabisch, H
Hochhaus, A
Zander, AR
Citation: B. Fehse et al., Real-time quantitative y chromosome-specific PCR (QYCS-PCR) for monitoringhematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation, J HEMATH ST, 10(3), 2001, pp. 419-425
Authors:
Kruger, W
Kroger, N
Togel, F
Badbaran, A
Renges, H
Gieseking, F
Gutensohn, K
Janicke, F
Zander, AR
Citation: W. Kruger et al., Influence of preharvest tumor cell contamination in bone marrow or blood does not predict resultant tumor cell contamination of granulocyte colony-stimulating factor mobilized stem cells, J HEMATH ST, 10(2), 2001, pp. 303-307
Authors:
Togel, F
Datta, C
Badbaran, A
Kroger, N
Renges, H
Gieseking, F
Janicke, F
Zander, AR
Kruger, W
Citation: F. Togel et al., Urokinase-like plasminogen activator receptor expression on disseminated breast cancer cells, J HEMATH ST, 10(1), 2001, pp. 141-145
Authors:
Kruger, WH
Jung, R
Detlefsen, B
Mumme, S
Badbaran, A
Brandner, J
Renges, H
Kroger, N
Zander, AR
Citation: Wh. Kruger et al., Interference of cytokeratin-20 and mammaglobin-reverse-transcriptase polymerase chain assays designed for the detection of disseminated cancer cells, MED ONCOL, 18(1), 2001, pp. 33-38
Authors:
Kroger, N
Zabelina, T
Kruger, W
Renges, H
Stute, N
Durken, M
von Finkenstein, FG
Erttmann, R
Kabisch, H
Schafhausen, P
Jaburg, N
Loliger, C
Zander, AR
Citation: N. Kroger et al., Anti-Thymocyte-Globulin as part of the preparative regimen prevents graft failure and severe Graft versus Host disease (GvHD) in allogeneic stem celltransplantation from unrelated donors, ANN HEMATOL, 80(4), 2001, pp. 209-215
Authors:
Kroger, N
Schetelig, J
Zabelina, T
Kruger, W
Renges, H
Stute, N
Schrum, J
Kabisch, H
Siegert, W
Zander, AR
Citation: N. Kroger et al., A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome, BONE MAR TR, 28(7), 2001, pp. 643-647
Authors:
Kroger, N
Zabelina, T
Kruger, W
Renges, H
Stute, N
Kabisch, H
Jaburg, N
Loliger, C
Krull, A
Zander, AR
Citation: N. Kroger et al., Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients, BONE MAR TR, 27(4), 2001, pp. 349-354
Authors:
Hanel, M
Kroger, N
Kroschinsky, F
Birkmann, J
Hanel, A
Herbst, R
Naumann, R
Friedrichsen, K
Ehninger, G
Zander, AR
Fiedler, F
Citation: M. Hanel et al., Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma, J CANC RES, 127(6), 2001, pp. 387-395
Authors:
Kroger, N
Zabelina, T
Kruger, W
Renges, H
Stute, N
Schrum, J
Kabisch, H
Schafhausen, P
Jaburg, N
Loliger, C
Schafer, P
Hinke, A
Zander, AR
Citation: N. Kroger et al., Patient cytomegalovirus seropositivity with or without reactivation is themost important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin, BR J HAEM, 113(4), 2001, pp. 1060-1071
Authors:
Kroger, N
Kruger, W
Renges, H
Zabelina, T
Stute, N
Jung, R
Wittkowsky, G
Kuse, R
Zander, AR
Citation: N. Kroger et al., Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma, BR J HAEM, 112(2), 2001, pp. 421-423
Authors:
Kruger, W
Kroger, N
Zander, AR
Citation: W. Kruger et al., MUC1 expression in hemopoietic tissues, J HEMATH ST, 9(4), 2000, pp. 409-410
Authors:
Kroger, N
Kruger, W
Renges, H
Zeller, W
Rauhoft, C
Loliger, C
Zander, AR
Citation: N. Kroger et al., Comparison of progenitor cell collection on day 4 or day 5 after steady-state stimulation with G-CSF alone in breast cancer patients: Influence on CD34(+) cell yield, subpopulation, and breast cancer cell contamination, J HEMATH ST, 9(1), 2000, pp. 111-117
Authors:
Fehse, B
Richters, A
Putimtseva-Scharf, K
Klump, H
Li, ZX
Ostertag, W
Zander, AR
Baum, C
Citation: B. Fehse et al., CD34 splice variant: An attractive marker for selection of gene-modified cells, MOL THER, 1(5), 2000, pp. 448-456
Authors:
Hanel, M
Kroger, N
Hoffknecht, MM
Peters, SO
Metzner, B
Fiedler, F
Braumann, D
Schubert, JC
Illiger, HJ
Hanel, A
Kruger, WH
Zeller, W
Weh, HJ
Hossfeld, DK
Zander, AR
Citation: M. Hanel et al., ASHAP - an effective salvage therapy for recurrent and refractory malignant lymphomas, ANN HEMATOL, 79(6), 2000, pp. 304-311
Authors:
Clausen, J
Stockschlader, M
Fehse, N
Hassan, HT
Gabl, C
Zander, AR
Citation: J. Clausen et al., Blood-derived macrophage layers in the presence of hydrocortisone support myeloid progenitors in long-term cultures of CD34(+) cord blood and bone marrow cells, ANN HEMATOL, 79(2), 2000, pp. 59-65
Authors:
Kroger, N
Hoffknecht, M
Kruger, W
Zeller, W
Renges, H
Stute, N
Zschaber, R
Zander, AR
Citation: N. Kroger et al., Allogeneic bone marrow transplantation for refractory mantle cell lymphoma, ANN HEMATOL, 79(10), 2000, pp. 578-580
Authors:
Durken, M
Herrnring, C
Finckh, B
Nagel, S
Nielsen, P
Fischer, R
Berger, HM
Moison, RMW
Pichlmeier, U
Kohlschutter, B
Zander, AR
Kohlschutter, A
Citation: M. Durken et al., Impaired plasma antioxidative defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantation, FREE RAD B, 28(6), 2000, pp. 887-894
Authors:
Kroger, N
Zabelina, T
Sonnenberg, S
Kruger, W
Renges, H
Stute, N
Finkenstein, F
Mayer, U
Holstein, K
Fiedler, W
Colberg, H
Sonnen, R
Kuse, R
Braumann, D
Metzner, B
del Valle, F
Erttmann, R
Kabisch, H
Zander, AR
Citation: N. Kroger et al., Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia, BONE MAR TR, 26(7), 2000, pp. 711-716
Authors:
Damon, LE
Wolf, JL
Rugo, HS
Gold, E
Zander, AR
Cassidy, M
Cecchi, G
Cohen, N
Irwin, D
Tracy, M
Ries, CA
Linker, CA
Citation: Le. Damon et al., High-dose chemotherapy (CTM) for breast cancer, BONE MAR TR, 26(3), 2000, pp. 257-268
Authors:
Fehse, B
Goldmann, M
Frerk, O
Bulduk, M
Zander, AR
Citation: B. Fehse et al., Depletion of alloreactive donor T cells using immunomagnetic cell selection, BONE MAR TR, 25, 2000, pp. S39-S42
Authors:
Kuhlcke, K
Ayuk, FA
Li, Z
Lindemann, C
Schilz, A
Schade, UM
Fauser, AA
Zander, AR
Eckert, HG
Fehse, B
Citation: K. Kuhlcke et al., Retroviral transduction of T lymphocytes for suicide gene therapy in allogeneic stem cell transplantation, BONE MAR TR, 25, 2000, pp. S96-S98
Authors:
Simonsson, B
Totterman, T
Hokland, P
Lauria, F
Carella, AM
Fernandez, MN
Rozman, C
Ferrant, A
de Witte, T
Zander, AR
Meier, K
Hansson, F
Citation: B. Simonsson et al., Roquinimex (Linomide) vs placebo in AML after autologous bone marrow transplantation, BONE MAR TR, 25(11), 2000, pp. 1121-1127